 - No more than 2 prior chemotherapy regimens; no prior treatment with tyrosine kinase inhibitors or antibodies to the epidermal growth factor receptor EGOR or human epidermal growth factor receptor 2 HER2neu; prior chemotherapy or radiation therapy completed at least 4 weeks prior to treatment with GW572016 